GMPro^TM Plasmid Manufacturing

Meet clinical trial expectations, ready for regulatory submission

Appropriate for viral vector and mRNA production

ProBio GMPro^TM Plasmid for research and development and clinical use of advanced therapy

GMPro^TM plasmid DNA is appropriate for the production of viral vectors or mRNA therapeutics. The whole process, manufacturing environment and documentation are strictly controlled under comprehensive quality assurance, guarantee the product quality and compliant for early clinical stages and research and development. We are also able to provide documentations for regulatory submissions.

ProBio is dedicated to providing one-stop solution from plasmid production to viral vector production (Lentiviral vector or AAV) to clients.

Contact us

Expect MORE from GMPro^TM Plasmid

• 

  Speed to Clinic

  Fast delivery
  Support regulatory submissions
  

  Critical Quality Assurance

  Phase Appropriate Compliance (PAC)
  Customer Quality Verification (CQV)
• 

  Accumulated Experience

  • Over 500 manufacturing batches for clinical trials
  • Various downstream applications for CGT, mRNA vaccine, DNA vaccine, etc.
  • Global clients from China, USA, Korea, etc.

GMPro^TM is a service trademark applied by ProBio

Related Products

• Plasmid Manufacture
• Linearized DNA Manufacture

×

Expand personal information

First Name*

Last Name*

Country/Region* --Please select the Country-- Arg'en'tina Andorra Afghanistan Algeria Antigua & Barbuda Anguilla Albania Arm'en'ia Angola American Samoa Austria Australia Aruba Aland Island Azerbaijan Bosnia & Herzegovina Barbados Bangladesh Belgium British Virgin Islands Burkina Bulgaria Bahrain Burundi B'en'in Bermuda Brunei Bolivia Brazil Bhutan Bouvet Island Botswana Belarus Belize Canada C'en'tral African Republic Cote d'Ivoire Cook Islands Chile Cameroon Cambodia China China Hong Kong China Taiwan China Macao Colombia Cayman Islands Croatia Costa Rica Cuba Cape Verde Cyprus Czech Republic Chad Djibouti Democratic Republic of the Congo D'en'mark Dominica Dominican Republic Ecuador Estonia Egypt Eritrea El Salvador Ethiopia Equatorial Guinea Finland Fiji Federated States of Micronesia Faroe Islands Fr'en'ch polynesia France Fr'en'ch Guiana Gabon Great Britain Gr'en'ada Georgia Guernsey Ghana Germany Gibraltar Gre'en'land Gambia Guinea Guadeloupe Greece Guatemala Guam Guinea-Bissau Guyana Honduras Haiti Hungary Indonesia Ireland Israel India Iraq Iran Iceland Italy Jersey Jamaica Jordan Japan K'en'ya Kyrgyzstan Kiribati Kuwait Kazakhstan Laos Lebanon Liecht'en'stein Liberia Lesotho Lithuania Luxembourg Latvia Libya Morocco Monaco Moldova Madagascar Marshall islands Mali Myanmar (Burma) Mongolia Martinique Mauritania Montserrat Malta Mauritius Maldives Malawi Mexico Malaysia Mozambique Namibia New Caledonia Northern Mariana Islands Niger Nigeria Nicaragua Netherlands Norway Nepal Nauru New Zealand Oman Panama Peru Papua New Guinea Pakistan Poland Puerto Rico Portugal Palau Paraguay Qatar Réunion Romania Russian Federation Rwanda Republic of Serbia Republic of Macedonia Republic of the Congo Serbia Switzerland Saudi Arabia Seychelles Sri Lanka Sudan Swed'en' Singapore Scotland South Korea St. Lucia Slov'en'ia Spain Slovakia Sierra Leone San Marino S'en'egal Somalia Suriname Saint Barthélemy South Africa Samoa Sao Tome & Principe Syria Swaziland St. Vinc'en't & the Gr'en'adines St. Kitts & Nevis Turks & Caicos Islands Togo The Bahamas The Philippines Thailand Tajikistan Timor-Leste Turkm'en'istan Tunisia Turkey Trinidad & Tobago Tuvalu Tonga Tanzania United States of America (USA) Ukraine Uganda United Arab Emirates Uruguay Uzbekistan United States Virgin Islands Vatican City (The Holy See) V'en'ezuela Vietnam Vanuatu Wallis and Futuna Yem'en' Zambia Zimbabwe

State* Alaska Alabama Arkansas Arizona California Colorado Connecticut District of Columbia Delaware Florida Georgia Hawaii Iowa Idaho Illinois Indiana Kansas Kentucky Louisiana Massachusetts Maryland Maine Michigan Minnesota Missouri Mississippi Montana North Carolina North Dakota Nebraska New Hampshire New Jersey New Mexico Nevada New York Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Virginia Vermont Washington Wisconsin West Virginia Wyoming

State* Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Nova Scotia Northwest Territory Nunavut Territory Ontario Prince Edward Island Quebec Saskatchewan Yukon

State* Victoria Australian Capital Territory Tasmania NEW south wales Queensland South australia West Australia

Email Address*

Phone Number

Company Name*

Zip Code*

Services*

• ProPlasmid Manufacturing
• GMPro Plasmid Manufacturing
• Lentiviral vector One-stop Solution
• GMP Lentiviral Vector Manufacturing
• AAV One-stop Solution

Services*

• Single B Cell Antibody Discovery Service
• Fully Human Antibody Discovery by Transgenic Mice
• Antibody Humanization
• Cell Line Development
• IND-enabling CMC Service
• GMP manufacturing

Validate Code*

* I agree to the Terms of Use and Privacy Policy

 I agree to receive the latest news, information, promotions, webinars and services, and acknowledge that I can opt out any time.

Send

Send